Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India

R. Leon Ochiai, M. Imran Khan, Sajid B. Soofi, Dipika Sur, Suman Kanungo, Young Ae You, M. Atif Habib, Shah Muhammad Sahito, Byomkesh Manna, Shanta Dutta, Camilo J. Acosta, Mohammad Ali, Sujit K. Bhattacharya, Zulfiqar A. Bhutta, John D. Clemens

Research output: Contribution to journalArticle

Abstract

The geometric mean concentration (GMC) and the proportion maintaining a protective level (150 enzyme-linked immunosorbent assay (ELISA) units [ELU]/ml) 2 years following a single dose of 25 μg of injectable Vi capsular polysaccharide typhoid vaccine was measured against that of the control hepatitis A vaccine in children 2 to 16 years old in cluster randomized trials in Karachi and Kolkata. The GMC for the Vi group (1,428 ELU/ml) was statistically significantly different from the GMC of the control hepatitis A vaccine group (86 ELU/ml) after 6 weeks. A total of 117 children (95.1%) in the Vi group and 9 (7.5%) in the hepatitis A group showed a 4-fold rise in Vi IgG antibody concentrations at 6 weeks ( P <0.01). Protective antibody levels remained significantly different between the two groups at 2 years (38% in the Vi vaccine groups and 6% in the hepatitis A group [P <0.01]). A very small proportion of younger children (2 to 5 years old) maintained protective Vi IgG antibody levels at 2 years, a result that was not statistically significantly different compared to that for the hepatitis A group (38.1% versus 10.5%). The GMCs of the Vi IgG antibody after 2 years were 133 ELU/ml for children 2 to

Original languageEnglish (US)
Pages (from-to)661-666
Number of pages6
JournalClinical and Vaccine Immunology
Volume21
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Typhoid-Paratyphoid Vaccines
Pakistan
Polysaccharides
Hepatitis A
India
Enzyme-Linked Immunosorbent Assay
Hepatitis A Vaccines
Antibodies
Immunoglobulin G
Immunosorbents
Assays
Vaccines
Injections
Typhoid Vi polysaccharide vaccine
Enzymes

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)
  • Medicine(all)

Cite this

Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India. / Ochiai, R. Leon; Khan, M. Imran; Soofi, Sajid B.; Sur, Dipika; Kanungo, Suman; You, Young Ae; Habib, M. Atif; Sahito, Shah Muhammad; Manna, Byomkesh; Dutta, Shanta; Acosta, Camilo J.; Ali, Mohammad; Bhattacharya, Sujit K.; Bhutta, Zulfiqar A.; Clemens, John D.

In: Clinical and Vaccine Immunology, Vol. 21, No. 5, 2014, p. 661-666.

Research output: Contribution to journalArticle

Ochiai, RL, Khan, MI, Soofi, SB, Sur, D, Kanungo, S, You, YA, Habib, MA, Sahito, SM, Manna, B, Dutta, S, Acosta, CJ, Ali, M, Bhattacharya, SK, Bhutta, ZA & Clemens, JD 2014, 'Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India', Clinical and Vaccine Immunology, vol. 21, no. 5, pp. 661-666. https://doi.org/10.1128/CVI.00791-13
Ochiai, R. Leon ; Khan, M. Imran ; Soofi, Sajid B. ; Sur, Dipika ; Kanungo, Suman ; You, Young Ae ; Habib, M. Atif ; Sahito, Shah Muhammad ; Manna, Byomkesh ; Dutta, Shanta ; Acosta, Camilo J. ; Ali, Mohammad ; Bhattacharya, Sujit K. ; Bhutta, Zulfiqar A. ; Clemens, John D. / Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India. In: Clinical and Vaccine Immunology. 2014 ; Vol. 21, No. 5. pp. 661-666.
@article{e9e9cccef27e4a1d9a17ac54df485047,
title = "Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India",
abstract = "The geometric mean concentration (GMC) and the proportion maintaining a protective level (150 enzyme-linked immunosorbent assay (ELISA) units [ELU]/ml) 2 years following a single dose of 25 μg of injectable Vi capsular polysaccharide typhoid vaccine was measured against that of the control hepatitis A vaccine in children 2 to 16 years old in cluster randomized trials in Karachi and Kolkata. The GMC for the Vi group (1,428 ELU/ml) was statistically significantly different from the GMC of the control hepatitis A vaccine group (86 ELU/ml) after 6 weeks. A total of 117 children (95.1{\%}) in the Vi group and 9 (7.5{\%}) in the hepatitis A group showed a 4-fold rise in Vi IgG antibody concentrations at 6 weeks ( P <0.01). Protective antibody levels remained significantly different between the two groups at 2 years (38{\%} in the Vi vaccine groups and 6{\%} in the hepatitis A group [P <0.01]). A very small proportion of younger children (2 to 5 years old) maintained protective Vi IgG antibody levels at 2 years, a result that was not statistically significantly different compared to that for the hepatitis A group (38.1{\%} versus 10.5{\%}). The GMCs of the Vi IgG antibody after 2 years were 133 ELU/ml for children 2 to",
author = "Ochiai, {R. Leon} and Khan, {M. Imran} and Soofi, {Sajid B.} and Dipika Sur and Suman Kanungo and You, {Young Ae} and Habib, {M. Atif} and Sahito, {Shah Muhammad} and Byomkesh Manna and Shanta Dutta and Acosta, {Camilo J.} and Mohammad Ali and Bhattacharya, {Sujit K.} and Bhutta, {Zulfiqar A.} and Clemens, {John D.}",
year = "2014",
doi = "10.1128/CVI.00791-13",
language = "English (US)",
volume = "21",
pages = "661--666",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India

AU - Ochiai, R. Leon

AU - Khan, M. Imran

AU - Soofi, Sajid B.

AU - Sur, Dipika

AU - Kanungo, Suman

AU - You, Young Ae

AU - Habib, M. Atif

AU - Sahito, Shah Muhammad

AU - Manna, Byomkesh

AU - Dutta, Shanta

AU - Acosta, Camilo J.

AU - Ali, Mohammad

AU - Bhattacharya, Sujit K.

AU - Bhutta, Zulfiqar A.

AU - Clemens, John D.

PY - 2014

Y1 - 2014

N2 - The geometric mean concentration (GMC) and the proportion maintaining a protective level (150 enzyme-linked immunosorbent assay (ELISA) units [ELU]/ml) 2 years following a single dose of 25 μg of injectable Vi capsular polysaccharide typhoid vaccine was measured against that of the control hepatitis A vaccine in children 2 to 16 years old in cluster randomized trials in Karachi and Kolkata. The GMC for the Vi group (1,428 ELU/ml) was statistically significantly different from the GMC of the control hepatitis A vaccine group (86 ELU/ml) after 6 weeks. A total of 117 children (95.1%) in the Vi group and 9 (7.5%) in the hepatitis A group showed a 4-fold rise in Vi IgG antibody concentrations at 6 weeks ( P <0.01). Protective antibody levels remained significantly different between the two groups at 2 years (38% in the Vi vaccine groups and 6% in the hepatitis A group [P <0.01]). A very small proportion of younger children (2 to 5 years old) maintained protective Vi IgG antibody levels at 2 years, a result that was not statistically significantly different compared to that for the hepatitis A group (38.1% versus 10.5%). The GMCs of the Vi IgG antibody after 2 years were 133 ELU/ml for children 2 to

AB - The geometric mean concentration (GMC) and the proportion maintaining a protective level (150 enzyme-linked immunosorbent assay (ELISA) units [ELU]/ml) 2 years following a single dose of 25 μg of injectable Vi capsular polysaccharide typhoid vaccine was measured against that of the control hepatitis A vaccine in children 2 to 16 years old in cluster randomized trials in Karachi and Kolkata. The GMC for the Vi group (1,428 ELU/ml) was statistically significantly different from the GMC of the control hepatitis A vaccine group (86 ELU/ml) after 6 weeks. A total of 117 children (95.1%) in the Vi group and 9 (7.5%) in the hepatitis A group showed a 4-fold rise in Vi IgG antibody concentrations at 6 weeks ( P <0.01). Protective antibody levels remained significantly different between the two groups at 2 years (38% in the Vi vaccine groups and 6% in the hepatitis A group [P <0.01]). A very small proportion of younger children (2 to 5 years old) maintained protective Vi IgG antibody levels at 2 years, a result that was not statistically significantly different compared to that for the hepatitis A group (38.1% versus 10.5%). The GMCs of the Vi IgG antibody after 2 years were 133 ELU/ml for children 2 to

UR - http://www.scopus.com/inward/record.url?scp=84899719542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899719542&partnerID=8YFLogxK

U2 - 10.1128/CVI.00791-13

DO - 10.1128/CVI.00791-13

M3 - Article

C2 - 24599532

AN - SCOPUS:84899719542

VL - 21

SP - 661

EP - 666

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 5

ER -